jump to content  sitemap
Division of Infectious Diseases : Department of Internal Medicine : College of Medicine : The Ohio State University
http://internalmedicine.osu.edu/cardiovascular//infectiousdiseases/6747.cfm

 
Chad A. Rappleye, Ph.D.
:: Directory ::
Faculty
Larry S. Schlesinger
John Gunn, PhD
Susan L. Koletar, MD
Jesse Kwiek, PhD
William E. Maher, MD
Julie E. Mangino, MD
Stanley I. Martin, MD
Bradford S. McGwire, MD, PhD
Michael F. Para, MD
Chad A. Rappleye, Ph.D.
Stephanie Seveau, PhD
Kurt B. Stevenson, MD, MPH
Joanne Turner, PhD
Shu-Hua Wang, Md, MPH&TM
David A. Wininger, MD
Jeremy D. Young, MD, MPH
Staff
Fellows

Home > Directory > Faculty > Chad A. Rappleye, Ph.D.

Chad A. Rappleye, Ph.D.                         

Assistant Professor of Microbiology
Center for Microbial Interface Biology

540 Biological Sciences
484 W. 12th. Avenue
Columbus, Ohio 43210
Phone: (614) 247-2718
E-mail: rappleye.1@osu.edu

Dr Rappleye joined the faculty in 2006.

Research Interests

We are interested in the molecular mechanisms that underlie the virulence of the respiratory fungal pathogen Histoplasma capsulatum, the causative agent of histoplasmosis.  In particular, we study the interaction between Histoplasma yeasts and their primary host cell, the mammalian macrophage.  Unlike opportunistic pathogens, Histoplasma can cause disease in immunocompetent hosts, implying that Histoplasma has specific mechanisms designed to promote pathogenesis.  One of these mechanisms is the elaboration of a cell wall polysaccharide, alpha-(1,3)-glucan, on the cell surface, which effectively masks the underlying immunostimulatory beta-glucans from detection by the host.  The only other virulence factor identified to date is a secreted molecule of unknown function.  With a genome harboring an estimated 10,000 genes, we have only scratched the surface in defining the genes important for Histoplasma virulence.

Our lab is employing genomics-based and molecular genetic approaches to identify additional factors contributing to the pathogenesis of Histoplasma.  The completion of the Histoplasma genome sequence has enabled the construction of microarrays that are used to determine the transcriptional profile of Histoplasma under various conditions, including infection of macrophages.  Once candidate genes have been identified, their importance in virulence is assessed through (i) the creation of loss of function mutants (i.e gene knock-outs) or gene depletion strains (via RNA interference) and (ii) the use of mutant strains in infection studies.  Excellent animal models of disease exist for Histoplasma as well as in vitro culture systems which facilitate more detailed studies to dissect the effect of fungal proteins at the cellular level.

To provide a more complete description of the molecular basis of fungal pathogenesis, our research also investigates the host side of the host-pathogen equation.  Using retroviral and lentiviral RNA interference systems to reduce host gene functions, we can now test the involvement of host molecules in the response to Histoplasma infection.  This ability to perform loss of function experiments in both the host and pathogen combine into a powerful system to define fungal virulence factors and the cognate host pathways targeted. 

Education

B.S. Biology, University of Utah (1995)
Ph.D. Biology, University of California, San Diego (2002)
Postdoctoral research, Washington University School of Medicine, St. Louis

Links

Center for Microbial Interface Biology

Recent Publications

 

 

 


Department of Internal Medicine http://www.internalmedicine.osu.edu

The Ohio State University | College of Medicine
Department of Internal Medicine | Division of Infectious Diseases
N1147 Doan Hall | 410 W. 10th Avenue | Columbus, OH 43210-1240
Ph: 614.293.8732 | Contact Us